The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Modeling Intraperitoneal Insulin Absorption in Patients with Type 1 Diabetes
Open accessAbstract
Standard insulin therapy to treat type 1 diabetes (T1D) consists of exogenous insulin administration through the subcutaneous (SC) tissue. Despite recent advances in insulin formulations, the SC route still suffers from delays and large inter/intra-subject variability that limiting optimal glucose control. Intraperitoneal (IP) insulin administration, despite its higher invasiveness, was shown to represent a valid alternative to the SC one. To date, no mathematical model describing the absorption and distribution of insulin after IP administration is available. Here, we aim to fill this gap by using data from eight patients with T1D, treated by implanted IP pump, studied in a hospitalized setting, with frequent measurements of plasma insulin and glucose concentration. A battery of models describing insulin kinetics after IP administration were tested. Model comparison and selection were performed based on model ability to predict the data, precision of parameters and parsimony criteria. The selected model assumed that the insulin absorption from the IP space was described by a linear, two-compartment model, coupled with a two-compartment model of whole-body insulin kinetics with hepatic insulin extraction controlled by hepatic insulin. Future developments include model incorporation into the UVa/Padova T1D Simulator for testing open- and closed-loop therapies with IP insulin administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Weighted residuals of the selected model in each subject. Dashed line represents zero value, while dashed-dotted lines represent [−1, +1] interval.](https://figures.cochat.ai/paper-figures/de9166ade1bd4537a9bebf37d2cdc783/modeling-intraperitoneal-insulin-absorption-in-patients-with-type-1-diabetes-figure-3.jpg)
![Figure 4 Simulated plasma insulin concentration after different bolus injection amounts (5U, red; 10U green and 15U blue) of U-400 regular insulin using the proposed IP model (continuous line) vs. U-100 fast-acting insulin concentration obtained with the SC model incorporated into the UVa/Padova T1D Simulator [15] (dashed line). Median estimated parameters were used to simulate both the IP and SC routes.](https://figures.cochat.ai/paper-figures/614659fb504a445d996770fa6117aad6/modeling-intraperitoneal-insulin-absorption-in-patients-with-type-1-diabetes-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the intraperitoneal (IP) absorption of insulin was modeled; 77,78”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kass, R. E., & Raftery, A. E. (1995) · Journal of the American Statistical Association · doi:10.1080/01621459.1995.10476572 · Cited by 12,558
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760
Self-citationA model of the kinetics of insulin in man
Sherwin, R. S., Kramer, K. J., Tobin, J. D., Insel, P. A., Liljenquist, J. E., Berman, M., & Andres, R. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107697 · Cited by 460 · cited 2×
“Another possible limitation is that, in this work, the whole-body insulin kinetics were described by a two-compartment model, even if a more physiological but complicated threecompartment model has also been proposed [20].”
MethodDAISY: A new software tool to test global identifiability of biological and physiological systems
Bellu, G., Saccomani, M. P., Audoly, S., & D’Angiò, L. (2007) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2007.07.002 · Cited by 452 · cited 1×
“The a priori identifiability of all the models was assessed using the software DAISY [19].”
MethodThe UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day
Visentin, R., Campos-Náñez, E., Schiavon, M., Lv, D., Vettoretti, M., Breton, M., Kovatchev, B. P., Dalla Man, C., & Cobelli, C. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818757747 · Cited by 280 · cited 8×
“Specifically, for all the models, a priori information on whole-body insulin kinetics parameters VI, m1, CL and HEb has been used to improve their numerical identifiability [15].”
BackgroundMethodInfluentialSelf-citationSimulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes
Wilinska, M. E., Chassin, L. J., Acerini, C. L., Allen, J. M., Dunger, D. B., & Hovorka, R. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400117 · Cited by 244 · cited 1×
“Moreover, a model of IP insulin absorption would be also an important component of in silico platforms, such as the UVa/Padova [14,15], the Cambridge [16] and the AIDA [17] T1D simulators, to develop and test new open- and closed-loop insulin treatment strategies.”
BackgroundRenard, E., Place, J., Cantwell, M., Chevassus, H., & Palerm, C. C. (2010) · Diabetes Care · doi:10.2337/dc09-1080 · Cited by 176 · cited 5×
“No information about complications due to IP insulin administration was reported in the original paper, where one can find detailed protocol description [13].”
BackgroundMethodInfluentialA minimal model of insulin secretion and kinetics to assess hepatic insulin extraction
TOFFOLO, G. M., Campioni, M., Basu, R., Rizza, R. A., & Cobelli, C. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00473.2004 · Cited by 150 · cited 2×
“Weighted residuals, defined as (data-model prediction)/SD, with SD standard deviation of the measurement error on insulin data [22], of the selected model in each subject are reported in Figure 3.”
MethodSelf-citationThe kinetics of insulin in man. II. Role of the liver
Ferrannini, E., & Cobelli, C. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030202 · Cited by 115 · cited 1×
“This suggests that the hepatic insulin extraction process saturates at high intrahepatic insulin level, in agreement with what reported in previous studies [25].”
ResultSelf-citationDassau, E., Renard, E., Place, J., Farret, A., Pelletier, M., Lee, J., Huyett, L. M., Chakrabarty, A., Doyle, F. J., & Zisser, H. C. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12999 · Cited by 94 · cited 1×
“IP insulin delivery recently raised interest in the diabetes community as a promising alternative to the conventional SC route [11,13] thanks to its faster pharmacokinetics and pharmacodynamics [5,6].”
Background
Cited by
Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility
Cobelli, C., & Kovatchev, B. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231195081 · Cited by 46
“…beyond its initial single-meal realm of application; 73 models of acetaminophen pharmacokinetic and long-acting insulin were introduced; 74-76 the intraperitoneal (IP) absorption of insulin was modeled; 77,78 and replay simulation and insulin sensitivity assessment techniques were developed.”
MethodSelf-citationEngineered nanoparticles in non-invasive insulin delivery for precision therapeutics of diabetes
Adwani, G., Bharti, S., & Kumar, A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133437 · Cited by 20
An Intelligent Model-Based Effective Approach for Glycemic Control in Type-1 Diabetes
Khaqan, A., Nauman, A., Shuja, S., Khurshaid, T., & Kim, K.-C. (2022) · Sensors · doi:10.3390/s22207773 · Cited by 14
“This research study deals with the design of Intraperitoneal (IP) insulin control for the distribution and absorption of insulin [12].”
Lo Presti, J., Galderisi, A., Doyle, F. J., Zisser, H. C., Dassau, E., Renard, E., Toffanin, C., & Cobelli, C. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221076559 · Cited by 12
Self-citationIdentifiable prediction animal model for the bi-hormonal intraperitoneal artificial pancreas
Benam, K. D., Khoshamadi, H., Åm, M. K., Stavdahl, Ø., Gros, S., & Fougner, A. L. (2022) · Journal of Process Control · doi:10.1016/j.jprocont.2022.11.008 · Cited by 11
Metadata
- Authors
- Schiavon, M., Cobelli, C., & Dalla Man, C.
- Affiliations
- University of Padua (IT)
- Department of Information Engineering, University of Padova, 35131 Padova, Italy
- Venue
- Metabolites
- Publisher
- MDPI AG
- Published
- 2021-09-03
- Volume
- 11
- Issue
- 9
- Pages
- 600
- ISSN
- 2218-1989 (ISSN-L)
- PMC
- PMC8465342
- OpenAlex
- W3197373782
- Semantic Scholar
- c2277492a703bfeefb867cb8337183cd726105ee
- Cited by
- 6
- References
- 26
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 3
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Metabolites (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca (“Departments of Excellence” (Law 232/2016))
- Università degli Studi di Padova (SID Networking Project 2019)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 1 diabetes, insulin absorption, insulin kinetics, mathematical modeling, two-compartment model, hepatic insulin extraction, insulin pump, plasma insulin, glycemic control, artificial pancreas
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modeling Intraperitoneal Insulin Absorption in Patients with Type 1 Diabetes. https://app.cochat.ai/papers/10.3390/metabo11090600
- The paper
- Schiavon, M., Cobelli, C., & Dalla Man, C. (2021). Modeling Intraperitoneal Insulin Absorption in Patients with Type 1 Diabetes. Metabolites. https://doi.org/10.3390/metabo11090600
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.